Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Beam Therapeutics
BEAM
$2.76B
| $2.31M | ﹤0.01% |
82,644
+60,223
| +269% | +$1.3M |
|
2577
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.48B
| $2.31M | ﹤0.01% |
61,720
-10,770
| -15% | -$397K |
|
2578
GoPro
GPRO
$110M
| $2.3M | ﹤0.01% |
483,874
+18,422
| +4% | +$69.9K |
|
|
CLVS
2579
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.3M | ﹤0.01% |
341,321
+58,179
| +21% | +$441K |
|
|
ALTA
2580
DELISTED
Altabancorp
ALTA
| $2.3M | ﹤0.01% |
102,187
-5,827
| -5% | -$120K |
|
|
STR
2581
DELISTED
Sitio Royalties
STR
| $2.29M | ﹤0.01% |
178,896
-1,933
| -1% | -$20.3K |
|
|
TARO
2582
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $2.29M | ﹤0.01% |
34,435
-761
| -2% | -$51K |
|
|
ODT
2583
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $2.28M | ﹤0.01% |
53,812
+6,073
| +13% | +$197K |
|
2584
Allient
ALNT
$1.89B
| $2.28M | ﹤0.01% |
96,816
-124,238
| -56% | -$2.59M |
|
2585
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
| $2.28M | ﹤0.01% |
13,790
-2,375
| -15% | -$359K |
|
2586
CEL-SCI Corp
CVM
$26.9M
| $2.27M | ﹤0.01% |
5,080
+1,018
| +25% | +$418K |
|
|
PRVB
2587
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $2.27M | ﹤0.01% |
161,172
+138,666
| +616% | +$1.75M |
|
2588
Corbus Pharmaceuticals
CRBP
$195M
| $2.27M | ﹤0.01% |
9,021
+1,757
| +24% | +$355K |
|
2589
Viking Therapeutics
VKTX
$3.87B
| $2.27M | ﹤0.01% |
314,682
-486
| -0.2% | -$3.23K |
|
2590
iShares MSCI EAFE Value ETF
EFV
$30.1B
| $2.27M | ﹤0.01% |
56,704
+7,456
| +15% | +$284K |
|
2591
Schwab US Large- Cap ETF
SCHX
$74.9B
| $2.27M | ﹤0.01% |
183,402
+23,928
| +15% | +$279K |
|
|
FBMS
2592
DELISTED
The First Bancshares, Inc.
FBMS
| $2.27M | ﹤0.01% |
100,707
+6,730
| +7% | +$137K |
|
2593
Merchants Bancorp
MBIN
$2.52B
| $2.26M | ﹤0.01% |
183,341
-21,733
| -11% | -$230K |
|
|
TSC
2594
DELISTED
TriState Capital Holdings, Inc.
TSC
| $2.26M | ﹤0.01% |
143,805
-267,532
| -65% | -$3.64M |
|
2595
Tower Semiconductor
TSEM
$30B
| $2.26M | ﹤0.01% |
118,239
-9,640
| -8% | -$185K |
|
|
CNBKA
2596
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $2.25M | ﹤0.01% |
29,018
-6,555
| -18% | -$457K |
|
2597
Sierra Bancorp
BSRR
$532M
| $2.25M | ﹤0.01% |
119,145
-8,652
| -7% | -$156K |
|
2598
Movado Group
MOV
$803M
| $2.25M | ﹤0.01% |
207,330
-29,990
| -13% | -$324K |
|
|
COWN
2599
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $2.25M | ﹤0.01% |
138,554
-5,909
| -4% | -$71.7K |
|
2600
OrthoPediatrics
KIDS
$648M
| $2.24M | ﹤0.01% |
51,132
+7,409
| +17% | +$333K |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.